Logo
x

Search

Subscribe Now

Exclusive

Exclusive Interview with PharmaShots: Anita Holz of Boehringer Ingelheim And Alanna Morris of Emory University Share Insight on Hear Your Heart

Exclusive Interview with PharmaShots: Anita Holz of Boehringer Ingelheim And Alanna Morris of Emory University Share Insight on He...

  • May 16, 2022
Teva Signs an Exclusive WW License Agreement with Modag to Develop Anle138b and Sery433 for Neurodegenerative Disease

Teva Signs an Exclusive WW License Agreement with Modag to Develop Anle138b and Sery433 for Neurodegenerative Disease

  • October 27, 2021
Selecta Enters into an Exclusive License Agreement with Genovis to Advance IgG Protease in Gene Therapy and Autoimmune Disease

Selecta Enters into an Exclusive License Agreement with Genovis to Advance IgG Protease in Gene Therapy and Autoimmune Disease

  • October 22, 2021
SpringWorks Enters into an Exclusive WW License Agreement with Academic Institutions to Advance Portfolio of Mutation-Selective EGFR Inhibitors

SpringWorks Enters into an Exclusive WW License Agreement with Academic Institutions to Advance Portfolio of Mutation-Selective EG...

  • October 20, 2021
Lipocine Enters into an Exclusive License Agreement with Antares to Commercialize Tlando in the US

Lipocine Enters into an Exclusive License Agreement with Antares to Commercialize Tlando in the US

  • October 19, 2021
Ipsen Signs an Exclusive WW Collaboration with Accent to Develop and Commercialize METTL3 Program

Ipsen Signs an Exclusive WW Collaboration with Accent to Develop and Commercialize METTL3 Program

  • October 18, 2021
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2024 PharmaShots - All Rights Reserved.